Investor Information

News

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

View News

Summit Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

View News

More Information

Share Price

NASDAQ: SMMT

20.50 USD

10-Feb-2025 16:00 UTC-5

More Information

SEC Filings

Current report filing

View News

Statement of changes in beneficial ownership of securities

View News

More Information

Email Alerts